When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   The United States Food and Drug Administration and the European Medicines Agency have approved weight loss medications for adults with either a body-mass index (BMI) of at least 30, or a body-mass index of at least 27 with at least one weight-related comorbidity. This patient population is considered to have sufficiently high baseline health ...

3. Liraglutide - Wikipedia

   en.wikipedia.org/wiki/Liraglutide

   Liraglutide was approved by the US Food and Drug Administration (FDA) in 2014, [31] and by the European Medicines Agency (EMA) in 2015, [5] for adults with a body mass index (BMI) of 30 or greater (obesity) or a BMI of 27 or greater (overweight) who have at least one weight-related condition.

4. Naltrexone/bupropion - Wikipedia

   en.wikipedia.org/wiki/Naltrexone/bupropion

   Naltrexone/bupropion, sold under the brand name Contrave among others, is a fixed-dose combination medication for the management of chronic obesity in adults in combination with a reduced-calorie diet and increased physical activity. [4] [6] It contains naltrexone, an opioid antagonist, and bupropion, an aminoketone atypical antidepressant. [4]

5. 15 Alternatives to Ozempic for Weight Loss - AOL

   www.aol.com/15-alternatives-ozempic-weight-loss...

   Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss — when a drug is prescribed for something it’s not approved for.

6. What Is the Maximum Dose of Ozempic for Weight Loss ... - AOL

   www.aol.com/lifestyle/maximum-dose-ozempic...

   What Is the Maximum Dose of Ozempic for Weight Loss? The maximum dose of Ozempic is 2.0 mg, to be taken once weekly. It is an injectable medication approved for diabetes management, though people ...

7. Phentermine/topiramate - Wikipedia

   en.wikipedia.org/wiki/Phentermine/topiramate

   In the US, the drug label contains warnings for increased heart rate, suicidal behavior and ideation, glaucoma, mood and sleep disorders, creatinine elevation, and metabolic acidosis. Some of these warnings are based on historical observations in epilepsy patients taking topiramate.